Nawal Bendris

Nawal Bendris, PhD, currently serves as Senior Director of Clinical Science at Dren Bio, Inc., since April 2025. Previously, Nawal held various roles at Kura Oncology, Inc., including Director and Associate Director of Clinical Science, contributing significantly to clinical programs. At Merck, Nawal worked as a Clinical Scientist with a focus on oncology, following a position as a Scientist in Biomarker/Clinical Science at Peloton Therapeutics, where pivotal projects supported clinical goals and enhanced global company recognition. Nawal's early career included a postdoctoral research position at UT Southwestern Medical Center, specializing in cancer metastasis. Nawal obtained a Ph.D. in Biology from the University of Montpellier, along with a Master’s degree in Developmental Biology and a Bachelor of Science in Biochemistry and Molecular Biology.